About Certara
Certara is a global leader in drug development solutions, serving the pharmaceutical, biotechnology, and contract research organization (CRO) sectors. With over 1,550 employees across more than 30 countries—28% holding PhDs—Certara integrates science, technology, and regulatory expertise to transform drug development from molecule to market. The company's comprehensive portfolio spans software platforms and professional services that address every phase of drug development, from discovery through market access and commercialization. Certara's software solutions include Phoenix for PK/PD analysis, Simcyp for physiologically-based pharmacokinetic (PBPK) modeling, Pinnacle 21 for data standardization and validation, GlobalSubmit for eCTD submissions, BaseCase for market access value stories, and Certara.AI—an AI platform designed specifically for life sciences. The company's CoAuthor platform leverages generative AI for regulatory writing, while D360 provides scientific informatics for molecular analysis. On the services side, Certara offers modeling and simulation, biometrics and data science, drug development support, regulatory strategy, and real-world evidence and market access consulting. The company specializes in Model-Informed Drug Development (MIDD), using predictive biosimulation to reduce development risk and accelerate decision-making. Certara maintains Centers of Excellence addressing complex therapeutic challenges in oncology, pediatrics, rare diseases, and other specialized areas. The company's mission is to transform drug development for good, helping clients optimize trial design, achieve regulatory milestones, demonstrate value to payers, and ultimately bring safer, more effective therapies to patients worldwide.
Mission & Story
Mission
Transform drug development for good
Clinical Focus
Medical conditions and clinical areas addressed by Certara.
Who It Serves
Milestones & Awards
Recent Milestones
Launch of Certara.AI platform for life sciences; CoAuthor GenAI platform for regulatory writing; Non-Animal Navigator for regulatory compliance; expansion of therapeutic Centers of Excellence
Awards & Recognition
Regulatory adoption by agencies worldwide; recognized industry standards alignment
Social & Media
Latest Updates
Dosimetry tells you the dose. It doesn’t tell you the decision.
Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Company Details
- Employees
- 1001-5000
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.